BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26907217)

  • 1. Galectins and Immune Responses-Just How Do They Do Those Things They Do?
    Thiemann S; Baum LG
    Annu Rev Immunol; 2016 May; 34():243-64. PubMed ID: 26907217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
    Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
    Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin multimerization and lattice formation are regulated by linker region structure.
    Earl LA; Bi S; Baum LG
    Glycobiology; 2011 Jan; 21(1):6-12. PubMed ID: 20864568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
    Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
    Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of galectins in immunity and infection.
    Liu FT; Stowell SR
    Nat Rev Immunol; 2023 Aug; 23(8):479-494. PubMed ID: 36646848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins.
    Cederfur C; Salomonsson E; Nilsson J; Halim A; Oberg CT; Larson G; Nilsson UJ; Leffler H
    Glycobiology; 2008 May; 18(5):384-94. PubMed ID: 18263896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
    Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
    Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectins: their network and roles in immunity/tumor growth control.
    Kaltner H; Toegel S; Caballero GG; Manning JC; Ledeen RW; Gabius HJ
    Histochem Cell Biol; 2017 Feb; 147(2):239-256. PubMed ID: 28012132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
    Bi S; Earl LA; Jacobs L; Baum LG
    J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The galectin lattice at a glance.
    Nabi IR; Shankar J; Dennis JW
    J Cell Sci; 2015 Jul; 128(13):2213-9. PubMed ID: 26092931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering galectin-glycan interactions for immunotherapy and immunomodulation.
    Farhadi SA; Hudalla GA
    Exp Biol Med (Maywood); 2016 May; 241(10):1074-83. PubMed ID: 27229902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural, functional, and evolutionary aspects of galectins in aquatic mollusks: From a sweet tooth to the Trojan horse.
    Vasta GR; Feng C; Bianchet MA; Bachvaroff TR; Tasumi S
    Fish Shellfish Immunol; 2015 Sep; 46(1):94-106. PubMed ID: 25982395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays.
    Horlacher T; Oberli MA; Werz DB; Kröck L; Bufali S; Mishra R; Sobek J; Simons K; Hirashima M; Niki T; Seeberger PH
    Chembiochem; 2010 Jul; 11(11):1563-73. PubMed ID: 20572248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian galectins bind galactoseβ1-4fucose disaccharide, a unique structural component of protostomial N-type glycoproteins.
    Takeuchi T; Tamura M; Nishiyama K; Iwaki J; Hirabayashi J; Takahashi H; Natsugari H; Arata Y; Kasai K
    Biochem Biophys Res Commun; 2013 Jul; 436(3):509-13. PubMed ID: 23751344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced high-affinity glycoconjugate ligands of galectins.
    Hovorková M; Červený J; Bumba L; Pelantová H; Cvačka J; Křen V; Renaudet O; Goyard D; Bojarová P
    Bioorg Chem; 2023 Feb; 131():106279. PubMed ID: 36446202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation, galectins and cellular signaling.
    Boscher C; Dennis JW; Nabi IR
    Curr Opin Cell Biol; 2011 Aug; 23(4):383-92. PubMed ID: 21616652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of sugar chain recognition by galectins and its involvement in disease-associated glycosylation.
    Arikawa T; Simamura E; Shimada H; Nakamura T; Hatta T; Shoji H
    Congenit Anom (Kyoto); 2014 May; 54(2):77-81. PubMed ID: 24450300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
    Sato S; St-Pierre C; Bhaumik P; Nieminen J
    Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains.
    Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S
    FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.